SEYİTLER KİMYA SANAYİ A.Ş. Logo

SEYİTLER KİMYA SANAYİ A.Ş.

Manufacturer of medical tapes, wound dressings, and first aid plasters for the healthcare industry.

SEYKM | IS

Overview

Corporate Details

ISIN(s):
TRESEYT00011 (+2 more)
LEI:
789000QODBWOP1OPEQ85
Country:
Türkiye
Address:
Turgutlu 1. OSB 2007 Cad. No:5-7 Turgutlu, 45400 MANİSA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1991, Seyitler Kimya Sanayi A.Ş. is a leading manufacturer in the healthcare sector. The company specializes in producing a range of medical supplies, including medical adhesive tapes, wound dressings, first aid plasters, and capsicum rheumatism plasters. With a focus on quality management and continuous research and development, Seyitler Kimya aims to serve the healthcare industry by providing reliable products. The company's goal is to be a preferred manufacturer both in its domestic market and globally, driven by a commitment to customer satisfaction and high production standards.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-30 16:11
Management Discussion and Analysis
30.09.2025 Sorumluluk Beyanı Hk.
Turkish 21.5 KB
2025-10-30 16:11
Quarterly Report
30.09.2025 Faaliyet Raporu Hk.
Turkish 1.1 MB
2025-10-30 16:11
Report Publication Announcement
30.09.2025 Faaliyet Raporu Hk.
English 10.9 KB
2025-10-30 16:11
Annual / Quarterly Financial Statement
Financial Report
Turkish 2.3 MB
2025-10-30 16:11
Annual / Quarterly Financial Statement
Financial Report
English 2.5 MB
2025-10-23 17:07
Legal Proceedings Report
Marka İhlal Davası Hk
Turkish 51.4 KB
2025-10-17 17:04
Environmental & Social Information
Bağış Yapılması Hk.
Turkish 17.7 KB
2025-10-07 17:06
Legal Proceedings Report
Tazminat Davası Hk.
English 46.7 KB
2025-10-07 17:05
Legal Proceedings Report
Marka İhlal Davası Hk
Turkish 50.1 KB
2025-09-29 17:03
Audit Report / Information
Bağımsız Denetim Kuruluşunun Belirlenmesi
Turkish 29.1 KB
2025-09-29 17:02
Pre-Annual General Meeting Information
Genel Kurul Tescili Hk.
Turkish 364.0 KB
2025-09-29 17:02
Proxy Solicitation & Information Statement
Genel Kurul Tescili Hk.
Turkish 179.5 KB
2025-09-29 17:02
Pre-Annual General Meeting Information
Genel Kurul Tescili Hk.
Turkish 190.1 KB
2025-09-29 17:02
Pre-Annual General Meeting Information
Genel Kurul Tescili Hk.
Turkish 116.4 KB
2025-09-29 17:02
Post-Annual General Meeting Information
Genel Kurul Tescili Hk.
Turkish 684.5 KB

Automate Your Workflow. Get a real-time feed of all SEYİTLER KİMYA SANAYİ A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SEYİTLER KİMYA SANAYİ A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SEYİTLER KİMYA SANAYİ A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
InflaRx N.V. Logo
Develops complement system inhibitors for severe inflammatory diseases and immuno-dermatology.
United States of America IFRX
Inhibikase Therapeutics, Inc. Logo
Develops kinase inhibitors to treat neurodegenerative diseases like Parkinson's.
United States of America IKT
Inhibrx Biosciences, Inc. Logo
Clinical-stage biopharma developing novel biologic therapies for life-threatening cancers.
United States of America INBX
InMed Pharmaceuticals Inc. Logo
Develops cannabinoid drugs for unmet medical needs and supplies rare cannabinoids for B2B wellness.
United States of America INM
Inmune Bio, Inc. Logo
Develops immunotherapies reprogramming innate immunity for cancer, Alzheimer's, and inflammation.
United States of America INMB
Innate Pharma SA Logo
Developing first-in-class antibody immunotherapies for cancer via the innate immune system.
United States of America IPHA
INOVIO PHARMACEUTICALS, INC. Logo
Develops DNA medicines delivered via smart devices for cancer, HPV, and infectious diseases.
United States of America INO
Insight Molecular Diagnostics Inc. Logo
Develops molecular diagnostic tests for oncology and transplant monitoring for clinicians & researchers.
United States of America IMDX
INSMED Inc Logo
Develops and commercializes innovative therapies for serious and rare diseases.
United States of America INSM
Instil Bio, Inc. Logo
Developing autologous TIL cell therapies using a patient's own immune cells to fight solid tumors.
United States of America TIL

Talk to a Data Expert

Have a question? We'll get back to you promptly.